Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
January 12, 2024 16:43 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on January 10, 2024 from the Listing...
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
January 05, 2024 08:00 ET
|
Lifecore Biomedical, Inc.
Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for its term debt facility with Alcon and...
Lifecore Biomedical Provides Business Update
December 13, 2023 07:30 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
November 20, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that the U.S. Department of Justice (the “DOJ”) has declined to prosecute...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
October 18, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on October 12, 2023 from the Listing...
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
October 10, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
August 31, 2023 07:30 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (Nasdaq: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
August 22, 2023 16:06 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
August 22, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on August 17, 2023 from the Listing...
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
June 01, 2023 07:15 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., June 01, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), reported...